Hexalen
Active substance: Altretamine
Manufacturer: MGI Pharma
Extract from the prescribing information:
"HEXALEN capsules causes mild to moderate myelosuppression and neurotoxicity."
"The carcinogenic potential of HEXALEN capsules has not been studied in animals, but drugs with similar mechanisms of action have been shown to be carcinogenic."
The above has been extracted from the Hexalen prescribing information on the MGI Pharma webpages.